Lilly- Lilly NCD partnership

Non-communicable diseases (NCDs) like diabetes, heart disease and hypertension impact individuals and societies. Hypertension is a huge public health concern in India. This  results in a high mortality rate  on account of non-communicable diseases .

Lilly, an OPPI member company, launched a flagship project named UDAY in 2012 which aims to develop a cost-effective scalable ‘Comprehensive Diabetes and Hypertension Prevention and Management Program’ in India. There  is a separate team of counsellors for interpersonal communication to increase awareness about diabetes and hypertension. Through this approach, the programme will focus on sharing results with key stakeholders, including the government and the global health community, to encourage adoption of the best solutions and bridge the gap through advocacy at a government level.

This project has reached out to over 100,000 patients through screening and interpersonal communications, more than 12000 people through 462 street shows conducted at Vishakhapatnam, and to 140 community health workers.

Other Articles